SCHEMBL15977926

SCHEMBL15977926

c1cncc(-c2ccc(-c3ccc4c(-c5ccc6c(c5)C5(c7ccccc7-c7ccccc75)c5ccccc5-6)c5ccccc5c(-c5ccc6c(c5)C5(c7ccccc7-c7ccccc75)c5ccccc5-6)c4c3)nc2)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 5/20 0.46
CYP2A6 P11509 4/20 0.36
CYP3A4 P08684 1/20 0.36
CYP11B1 P15538 3/20 0.36
CYP11B2 P19099 2/20 0.36
PIK3CA P42336 1/20 0.36
CCNT1 O60563 1/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CDK9 P50750 1/20 0.35
TDP2 O95551 1/20 0.35
KIT P10721 1/20 0.35
PDPK1 O15530 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
PIM1 P11309 1/20 0.34
MAPK10 P53779 1/20 0.34
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977821 0.97 PDK2 (0.48) PDK2CYP2A6CYP3A4CYP11B1CYP11B2
SCHEMBL15977831 0.94 PDK2 (0.43) PDK2CYP2A6CYP3A4CYP11B1CYP11B2
SCHEMBL15977609 0.93 PDK2 (0.43) PDK2CYP2A6CYP3A4CYP11B1CYP11B2
SCHEMBL15977929 0.91 PDK2 (0.53) PDK2CYP2A6CYP3A4CYP11B1CYP11B2
SCHEMBL15977516 0.91 PDK2 (0.45) PDK2CYP2A6CYP3A4CYP11B1CYP11B2
SCHEMBL15977538 0.90 PDK2 (0.42) PDK2CYP11B1CYP11B2PIK3CACDK2
SCHEMBL15977588 0.90 PDK2 (0.44) PDK2CYP2A6CYP3A4CYP11B1CYP11B2
SCHEMBL15977827 0.89 PDK2 (0.45) PDK2CYP2A6CYP3A4CYP11B1CYP11B2
SCHEMBL19164546 0.88 PDK2 (0.54) PDK2CYP2A6CYP3A4CYP11B1CYP11B2
SCHEMBL15977830 0.87 PDK2 (0.43) PDK2CYP2A6CYP3A4CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 PDK2 924/4885CYP2A6 3184/4885CYP3A4 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.